
Semax is a synthetic nootropic peptide primarily used in Russia and Ukraine. It is known for its potential nootropic, neuroprotective, and neurorestorative effects. Outside these countries, including in the United States, Semax has neither been approved for use nor marketed.
This heptapeptide nootropic has a similar background and chemical profile to Noopept and Selank. Semax was created in 1982 by scientists at the Institute of Molecular Genetics within the Russian Academy of Sciences in Moscow. Researchers originally explored it as a possible therapy for stroke patients with brain injuries. However, further studies revealed its ability to enhance cognitive functions even in individuals without brain damage.
Semax acts as a stimulant for the central nervous system, supporting improvements in memory, concentration, mental clarity, physical endurance, and analytical thinking. Unlike traditional stimulants, Semax offers a unique approach to boosting mental performance without the jitters or crashes often associated with other cognitive enhancers. It is often considered to carry a lower risk of side effects.
What is Semax?
Semax is a heptapeptide, meaning it consists of seven amino acids (Met-Glu-His-Phe-Pro-Gly-Pro), derived from a fragment of adrenocorticotropic hormone (ACTH). Unlike ACTH, which influences cortisol levels, Semax focuses on brain function, promoting neuroprotection and cognitive enhancement. Originally developed in the 1980s by Russian scientists, it was initially used to aid recovery in stroke patients and those with brain injuries. [1]
Semax is most commonly administered as a nasal spray, which allows it to bypass the blood-brain barrier and act directly on the central nervous system. This intranasal route ensures fast absorption and targeted effects in the brain. There is also an injectable form of Semax available, though it is used less frequently outside clinical or research settings. While prescribed in Russia and some Eastern European countries, Semax remains investigational in the rest of the world, primarily used by researchers and biohackers. [2]
How Does Semax Work
The exact ways in which Semax works are not fully understood, but studies suggest its neuroprotective and restorative effects may be linked to the activation of the brain’s serotonin system along with increased production of brain-derived neurotrophic factor (BDNF) in the hippocampus. Semax has also been shown to influence a wide range of biological processes. Research indicates it can modulate immune responses by changing the expression of genes involved in immune cell activity and mobility, as well as boosting genes responsible for producing chemokines and immunoglobulins. [3]
Animal studies on rats further reveal that Semax affects genes tied to the development and function of blood vessels, suggesting its neuroprotective benefits may partly stem from both its immune-modulating properties and its impact on vascular health, particularly during periods of restricted blood flow.
A study published in 2006 examined how Semax influences cognitive functions. Researchers found that Semax administration in rats led to a 1.4-fold increase in BDNF protein levels and a 1.6-fold rise in trkB tyrosine phosphorylation within the hippocampus. Additionally, the study observed a threefold increase in exon III BDNF expression and a twofold rise in trkB mRNA levels. These findings support the idea that Semax exerts its effects through activation of the hippocampal BDNF/trkB pathway, which plays an important role in overall brain health and cognition. [4]
Boosting Attention and Thinking Processes
One of Semax’s best-known effects is its ability to improve memory and attention. In a 1996 study, healthy subjects given Semax during extended work shifts demonstrated improved attention and short-term memory, particularly when fatigued. The treatment group outperformed controls in memory tests conducted the following day, suggesting lasting cognitive benefits. These findings align with Semax’s ability to increase BDNF and support synaptic plasticity, which are essential for memory formation and retention. [5]
Treatment Applications
Semax has undergone significant research for its potential in treating various neurological conditions. In Russia, it is officially approved for use in stroke recovery, traumatic brain injuries, and cognitive impairments. Studies have found that Semax can speed up recovery in stroke patients by minimizing brain damage and enhancing motor function. Clinical trials show that patients receiving Semax alongside standard therapies tend to regain neurological functions more quickly than those relying on conventional treatment alone.
Beyond stroke, Semax has shown promise in managing optic nerve disorders and glaucoma. Studies suggest it can reduce the progression of optic nerve damage when combined with anti-inflammatory treatments. Its neuroprotective properties also make it a candidate for addressing neurodegenerative conditions, such as Alzheimer’s disease, where it may help mitigate amyloid beta aggregation, a hallmark of the disease. Additionally, Semax has been explored for its potential in treating attention-deficit hyperactivity disorder (ADHD) and anxiety.
Clinical Trials
Neuroprotective Benefits in Glaucomatous Optic Neuropathy
A 2001 study investigated Semax’s effects on glaucomatous optic neuropathy. Using electrophysiological and computer-based assessments, researchers found that Semax outperformed traditional neuroprotective treatments for glaucoma. They concluded its success was due to its strong neuroprotective and neurotrophic effects, highlighting its potential in supporting neurological and ocular health. [6]
Anti-Anxiety and Antidepressant Effects
Also in 2007, researchers examined how Semax affected exploratory behavior, anxiety, and depression-like symptoms in white rats. Chronic use did not change exploratory activity in stress-free environments but did produce noticeable anti-anxiety and antidepressant effects. These benefits were linked to increased serotonin activity and higher BDNF expression in the hippocampus. [3]
Potential for ADHD and Rett Syndrome Aid
In 2007, a paper in Medical Hypothesis proposed Semax as a potential treatment for ADHD and Rett Syndrome. The authors noted that animal studies showed Semax could enhance the effects of psychostimulants on dopamine release while also stimulating BDNF production in the brain. This dual action was thought to improve selective attention and influence brain development, making it a promising candidate for managing Rett Syndrome and ADHD. [7]
Memory and Learning Improvements in Prenatal Brain Injury
Another study explored Semax’s effects on learning and memory deficits in rats exposed to amphetamines before birth. Results showed that Semax helped reverse these cognitive impairments, suggesting it may support rehabilitation and neuroprotection in cases of prenatal brain damage. [8]
Anti-Inflammatory Effects After Stroke
Additional research indicates that Semax administration after cerebral ischemia reduces vascular damage and boosts neurotrophin mRNA synthesis in the brain. A 2013 study found that Semax had anti-inflammatory effects in rats with ischemic brain injury, lowering levels of vascular endothelial growth factor (VEGFA), which contributes to blood vessel formation and inflammation. [9]
Protective Effects in Ischemic Brain Injury
A 2017 study published in Molecular Genetics and Genomics highlighted Semax’s strong protective effects in rats with ischemic brain injury, a model for stroke. Researchers observed that Semax significantly influenced the immune response, enhancing antigen presentation pathways, amplifying ischemia’s impact on interferon signaling, and affecting immunoglobulin synthesis. The peptide also increased the expression of genes encoding the immunoglobulin heavy chain. These findings led scientists to propose that Semax’s neuroprotective action may involve “neuroimmune crosstalk” as well as unique properties of its Pro-Gly-Pro (PGP) component. [10]
Spinal Cord Injury Recovery
Additionally, more recent research demonstrated that Semax supports recovery from spinal cord injury (SCI) in mice by interacting with μ-opioid receptors in the brain. This interaction influences a protein called USP18, which helps control the removal of ubiquitin tags from another protein, FTO. By regulating this process, Semax reduces damage to lysosomal membranes, which is important for preventing cell death caused by inflammation and oxidative stress. [11]
Uses Beyond Cognition
Semax’s applications extend beyond cognitive enhancement. Its neuroprotective properties make it valuable for long-term brain health. Research suggests it can protect neurons from oxidative stress and glutamate toxicity, which are implicated in neurodegenerative diseases. In animal studies, Semax has been shown to improve neuronal survival under conditions of ischemia, a lack of blood flow that can lead to cell death. This makes it a potential peptide therapy for conditions like stroke and traumatic brain injury.
Semax also influences the immune and vascular systems, enhancing the expression of genes related to immune cell activity and blood vessel formation. These effects contribute to its neuroprotective role by supporting tissue repair and reducing inflammation in the brain. Furthermore, Semax has shown potential in reducing anxiety and improving mood, potentially making it a versatile tool for mental health and stress management.
Effects and Safety Profile
The effects of Semax are wide-ranging, impacting cognition, mood, and neuroprotection. By increasing BDNF and modulating neurotransmitters, it enhances learning, memory, and emotional stability. Its ability to improve cerebral blood flow ensures better oxygen and nutrient delivery to brain tissues, supporting overall brain health. In animal studies, Semax has demonstrated antidepressant-like and anxiolytic effects, suggesting potential benefits for depression and stress-related disorders.
Semax is generally well-tolerated, with minimal side effects reported. The most common side effect is mild nasal irritation from intranasal administration. Unlike many cognitive enhancers, Semax does not cause dependency or significant adverse reactions, even with extended use. However, to maintain effectiveness, some protocols recommend cycling its use to prevent adaptation.
Is Semax Legal In the US?
Currently, Semax is not approved by the FDA for medical use in the United States. It is classified as a research compound, meaning it can be legally purchased for laboratory and research purposes only and shouldn’t be self-administered. Semax is not available as a prescription medication, and its sale is generally limited to research supply companies.
Despite this, some people choose to use Semax off-label to explore its potential cognitive and neuroprotective benefits. However, using Semax outside of a research setting carries legal and potential health risks, as its safety and efficacy have not been evaluated for human use by US regulatory authorities.
Sourcing
USA
- LIMITLESS LIFE NOOTROPICS aka Biotech
-
Use Discount Code: EP20
Copied EP20
- SCANTIFIX
-
Use Discount Code: Exploringpeptides
Copied Exploringpeptides
Canada
Europe
- DNLABResearch
-
Use Discount Code: EP15
Copied EP15
- SCANTIFIX
-
Use Discount Code: Exploringpeptides
Copied Exploringpeptides
Australia
- LVLUPHEALTH
-
Use Discount Code: Exploringpeptides
Copied Exploringpeptides
- SCANTIFIX
-
Use Discount Code: Exploringpeptides
Copied Exploringpeptides
References
[1] National Center for Biotechnology Information (2025). PubChem Compound Summary for CID 9811102, Semax. Retrieved July 25, 2025 from https://pubchem.ncbi.nlm.nih.gov/compound/ACTH-_4-7_-Pro-Gly-Pro.
[2] Koroleva, S. & Myasoedov, N.. (2018). Semax as a Universal Drug for Therapy and Research. Biology Bulletin. 45. 589-600. 10.1134/S1062359018060055.
[3] Vilenskiĭ DA, Levitskaia NG, Andreeva LA, Alfeeva LIu, Kamenskiĭ AA, Miasoedov NF. [Effects of chronic Semax administration on exploratory activity and emotional reaction in white rats]. Ross Fiziol Zh Im I M Sechenova. 2007 Jun;93(6):661-9. Russian. PMID: 17850024.
[4] Dolotov OV, Karpenko EA, Inozemtseva LS, Seredenina TS, Levitskaya NG, Rozyczka J, Dubynina EV, Novosadova EV, Andreeva LA, Alfeeva LY, Kamensky AA, Grivennikov IA, Myasoedov NF, Engele J. Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus. Brain Res. 2006 Oct 30;1117(1):54-60. doi: 10.1016/j.brainres.2006.07.108. Epub 2006 Sep 22. PMID: 16996037.
[5] Kaplan, Alexander & Kochetova, Arina & Nezavibathko, V. & Rjasina, T. & Ashmarin, I.. (1996). Synthetic ACTH analogue Semax displays nootropic‐like activity in humans. Neuroscience Research Communications - NEUROSCI RES COMMUN. 19. 115-123. 10.1002/(SICI)1520-6769(199609)19:23.0.CO;2-B.
[6] Kurysheva NI, Shpak AA, Ioĭleva EE, Galanter LI, Nagornova ND, Shubina NIu, Shlyshalova NN. "Semaks" v lechenii glaukomatoznoĭ opticheskoĭ neĭropatii u bol'nykh s normalizovannym oftal'motonusom [Semax in the treatment of glaucomatous optic neuropathy in patients with normalized ophthalmic tone]. Vestn Oftalmol. 2001 Jul-Aug;117(4):5-8. Russian. PMID: 11569188.
[7] Tsai SJ. Semax, an analogue of adrenocorticotropin (4-10), is a potential agent for the treatment of attention-deficit hyperactivity disorder and Rett syndrome. Med Hypotheses. 2007;68(5):1144-6. doi: 10.1016/j.mehy.2006.07.017. Epub 2006 Sep 25. PMID: 16996699.
[8] Bashkatova V, Sudakov S, Rezvanova D, Prast H, Vanin A. Attenuation by a novel synthetic analogue of ACTH4-7 of the learning and memory deficits in juvenile rats treated with amphetamine in utero: role of nitric oxide. BMC Pharmacol. 2009 Nov 12;9(Suppl 2):A26. doi: 10.1186/1471-2210-9-S2-A26. PMCID: PMC2778896.
[9] Stavchanskiĭ VV, Tvorogova TV, Botsina AIu, Limborskaia SA, Skvortsova VI, Miasoedov NF, Dergunova LV. [The effect of semax and its C-end peptide PGP on Vegfa gene expression in the rat brain during incomplete global ischemia]. Mol Biol (Mosk). 2013 May-Jun;47(3):461-6. Russian. doi: 10.7868/s0026898413030166. PMID: 23888777.
[10] Medvedeva EV, Dmitrieva VG, Limborska SA, Myasoedov NF, Dergunova LV. Semax, an analog of ACTH(4-7), regulates expression of immune response genes during ischemic brain injury in rats. Mol Genet Genomics. 2017 Jun;292(3):635-653. doi: 10.1007/s00438-017-1297-1. Epub 2017 Mar 2. PMID: 28255762.
[11] Liu R, Chen Y, Huang H, Li X, Lv J, Jiang L, Jiang H, Wu C, Chen W, Xu H, Zhu Z, Cai H, Xiao J, Yin L, Ni W. Semax peptide targets the μ opioid receptor gene Oprm1 to promote deubiquitination and functional recovery after spinal cord injury in female mice. Br J Pharmacol. 2025 Jul 21. doi: 10.1111/bph.70122. Epub ahead of print. PMID: 40692165.
Table of content
- What is Semax?
- How Does Semax Work
- Treatment Applications
- Clinical Trials
- Neuroprotective Benefits in Glaucomatous Optic Neuropathy
- Anti-Anxiety and Antidepressant Effects
- Potential for ADHD and Rett Syndrome Aid
- Memory and Learning Improvements in Prenatal Brain Injury
- Anti-Inflammatory Effects After Stroke
- Protective Effects in Ischemic Brain Injury
- Spinal Cord Injury Recovery
- Uses Beyond Cognition
- Effects and Safety Profile
- Is Semax Legal In the US?
- References



